Cybin (CYBN) News Today $7.06 -0.11 (-1.53%) As of 08/15/2025 04:10 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSEC FilingsBuy This Stock CYBN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Cybin (OTCMKTS:CYBN) Shares Down 2.6% - Should You Sell?August 12, 2025 | marketbeat.comCybin CEO to Speak at Canaccord Genuity Growth ConferenceAugust 6, 2025 | tipranks.comCybin (OTCMKTS:CYBN) Shares Down 1.7% - Time to Sell?July 19, 2025 | marketbeat.comCybin Inc. Expands Market Strategy with New SEC FilingJuly 14, 2025 | tipranks.comCybin Inc. Secures $50 Million in Convertible Debenture DealJuly 10, 2025 | tipranks.comCybin Inc. Reports on Governance and ComplianceJuly 7, 2025 | tipranks.comCybin Inc. Advances Mental Health Innovations with Strategic Partnerships and Clinical ProgressJune 30, 2025 | tipranks.comCybin Secures $500 Million Financing to Boost Clinical ProgramsJune 30, 2025 | tipranks.comCybin (OTCMKTS:CYBN) Trading Up 3.9% - Still a Buy?June 27, 2025 | marketbeat.comCybin to Participate in the 2025 Psychedelic Science ConferenceJune 11, 2025 | financialpost.comFCybin (OTCMKTS:CYBN) Shares Up 3.1% - Here's WhyJune 5, 2025 | marketbeat.comCybin (OTCMKTS:CYBN) Shares Down 0.5% - Time to Sell?May 16, 2025 | marketbeat.comCybin CEO to Speak at Healthcare Showcase, Highlighting Innovations in Mental Health TreatmentMay 14, 2025 | tipranks.comCybin to Participate in the Alliance Global Partners Healthcare Company ShowcaseMay 14, 2025 | financialpost.comFCybin to Participate in the Alliance Global Partners Healthcare Company ShowcaseMay 14, 2025 | financialpost.comFCybin to Participate at the 28th Annual Milken Institute Global ConferenceMay 1, 2025 | theglobeandmail.comCybin (OTCMKTS:CYBN) Shares Down 0.8% - Here's WhyApril 23, 2025 | marketbeat.comCybin (OTCMKTS:CYBN) Shares Down 5.7% - What's Next?April 4, 2025 | marketbeat.comCybin (OTCMKTS:CYBN) Stock Price Down 5.7% - What's Next?April 1, 2025 | marketbeat.comGuggenheim Initiates Coverage of Cybin (CYBN) with Buy RecommendationMarch 14, 2025 | msn.comCybin (OTCMKTS:CYBN) Shares Up 0.5% - Should You Buy?March 11, 2025 | marketbeat.comCybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025March 1, 2025 | insidermonkey.comCybin (OTCMKTS:CYBN) Trading 1.2% Higher - Time to Buy?February 14, 2025 | marketbeat.comCybin price target lowered to $150 from $190 at H.C. WainwrightFebruary 13, 2025 | markets.businessinsider.comCybin price target lowered to $73 from $86 at CanaccordFebruary 12, 2025 | markets.businessinsider.comCanaccord cuts Cybin stock target to $73, maintains Buy ratingFebruary 12, 2025 | msn.comCybin (OTCMKTS:CYBN) Shares Up 1.8% - Should You Buy?January 23, 2025 | marketbeat.comCybin: Paradigm Changing AmbitionsJanuary 20, 2025 | seekingalpha.comCybin Inc. Achieves Breakthroughs in Mental Health TreatmentJanuary 13, 2025 | tipranks.comCybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025January 9, 2025 | financialpost.comFCybin Reveals Promising Results in Depression TreatmentDecember 10, 2024 | tipranks.comCybin (OTCMKTS:CYBN) Shares Down 4.3% - Here's WhyNovember 28, 2024 | marketbeat.comCybin Inc. Advances in Mental Health TreatmentsNovember 25, 2024 | tipranks.comCybin (OTCMKTS:CYBN) Stock Price Up 0.2% - Should You Buy?November 6, 2024 | marketbeat.comCybin announces grant of patent in support of CYB005 phenethylamines programOctober 25, 2024 | markets.businessinsider.comBright Minds rally ends as psychedelic stocks extend volatilityOctober 16, 2024 | msn.comCybin Expands Clinical Team to Support CYB003 Phase 3 ProgramOctober 1, 2024 | finance.yahoo.comChewy executive conducted insider trading over pet insurance partnership, SEC saysSeptember 27, 2024 | ca.finance.yahoo.comClock is ticking for US recession, return of Fed's QE, says black swan fundSeptember 27, 2024 | ca.finance.yahoo.comCybin to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | finance.yahoo.comCybin Inc (R7E1.DU)August 30, 2024 | nz.finance.yahoo.comCybin Inc (R7E1.MU)August 30, 2024 | nz.finance.yahoo.comCybin (OTCMKTS:CYBN) Shares Down 0.2% August 28, 2024 | marketbeat.comBuy Rating Affirmed for Cybin Amid Advancements in Psychedelic Medicine and Strategic Regulatory ApproachesJuly 31, 2024 | markets.businessinsider.comCybin (OTCMKTS:CYBN) Trading Down 1.8%July 20, 2024 | marketbeat.comCybin (OTCMKTS:CYBN) Shares Down 2.7% June 27, 2024 | marketbeat.comCybin Provides Corporate Update and Highlights Upcoming Clinical MilestonesMay 6, 2024 | finance.yahoo.comCybin Provides Corporate Update and Highlights Upcoming Clinical MilestonesMay 6, 2024 | businesswire.comCybin Announces Publication of Research Manuscript in the Journal of Medicinal ChemistryApril 18, 2024 | businesswire.comCybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive DisorderApril 16, 2024 | businesswire.com Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address CYBN Media Mentions By Week CYBN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYBN News Sentiment▼1.110.65▲Average Medical News Sentiment CYBN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYBN Articles This Week▼10▲CYBN Articles Average Week Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sana Biotechnology News Today Gyre Therapeutics News Today Ginkgo Bioworks News Today Siga Technologies News Today Maravai LifeSciences News Today Arbutus Biopharma News Today Zevra Therapeutics News Today Dianthus Therapeutics News Today ProKidney News Today Taysha Gene Therapies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CYBN) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cybin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cybin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access